Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma

Clinical trial NCT01535989 · COMPLETED

Trial details

NCT number: NCT01535989
Sponsor: Cristiana Sessa
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma Refractory

Start date: 2011-12-01
Primary completion: 2016-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.